STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

NEPH NEPHROS INCORPORATED StockScouter® Report

6

StockScouter® Score

NEPHROS INCORPORATED, a micro cap value company in the capital goods sector, is expected to slightly underperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Short-term relative price momentum exhibits moderate strength. Postive/Neutral
  • Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like NEPH

 

Concerns

  • Moving average analysis for NEPH suggests weak price movement over the medium term. Negative
  • The multi-period measure of relative price change and consistency is below average. Negative/Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, value stocks will be neutral, and capital goods stocks will be neutral.

Expected Risk/Return

Progress: 60% done.
Progress: 40% done.
Low
High

Core Model Grades

C
C
C
D

Previous Ratings

6
4
7